June 28, 2002
- Waltham, MA
NeuroMetrix, Inc. today announced that Gary L. Gregory has joined the Company as Executive Vice President for Worldwide Sales. Mr. Gregory comes to NeuroMetrix with over 17 years of professional experience developed in progressively challenging roles across leading medical device companies. His leadership roles have spanned Sales Management, Marketing, Corporate Accounts and Business Development within Kendall, Baxter, Johnson & Johnson and PrimeSource Healthcare. Most recently, Mr. Gregory was Senior Vice President of Sales & Marketing for PrimeSource, the nation's leading manufacturer and distributor of specialty medical devices. Prior to that position, Gary held a number of senior roles within Johnson & Johnson and their Cordis Divisions. These included Director of Sales for the Western Region where he co-directed J&J's cardiology sales organization, and Director of Corporate Accounts where he built the corporate account department and business spanning all four Cordis Divisions.
"Gary's depth of experience, superb analytical skills, and commitment to outstanding performance will be a tremendous asset to our organization as we look to continue our rapid growth in the point-of-care neurodiagnostic market," said Shai N. Gozani, MD, PhD, CEO of NeuroMetrix. "The NC-stat is quickly becoming the standard of care in nerve conduction testing, and with Gary's guidance and leadership, we will see a further acceleration of product adoption."
The NC-stat system is in routine use by orthopedic surgeons, occupational physicians and corporations across the U.S. The product consists of single-use disposable biosensors and a compact electronic monitor that seamlessly integrates nerve conduction studies with an information service developed and managed by NeuroMetrix. The system conducts a test with the press of a button, analyzes patient data and returns test results to the clinician within minutes. The high diagnostic accuracy of the NC-stat system has been demonstrated in a number of studies published in leading medical journals.